CodeMap® Compliance Briefing: July 30, 2020
Editor's Welcome: In previous CodeMap® Compliance Briefings, we discussed the coding and Medicare reimbursement for differing types of COVID-19 testing and related services. These codes and the associated rules continue to evolve, so today we will cover all applicable codes related to COVID-19 testing in one comprehensive briefing. In addition, we will examine the rules that pertain to CLIA waived testing and which practitioners may order COVID-19 testing. Going forward, we anticipate that the AMA and CMS will continue to create new procedure codes concerning the pandemic, in particular, PLA codes unique to individual laboratories and diagnostic manufacturers. We will continue to update our readers concerning these developments as well. As always, please send your questions, comments, or suggestio....
Sorry, access to this content requires a current subscription.
Click here for publications catalog.
CPT copyright 2022 American Medical Association. All rights reserved.
* The responsibility for the content of any "National Correct Coding Policy" included in this product is with the Centers for Medicare and Medicaid
Services and no endorsement by the AMA is intended or should be implied. The AMA disclaims responsibility for any consequences or liability attributable to or related
to any use, nonuse, or interpretation of information contained in this product.